155 related articles for article (PubMed ID: 37292206)
1. The analysis of cathepsin L that mediates cellular SARS-CoV-2 infection leading to COVID-19 in head and neck squamous cell carcinoma.
Gao F; Wang X; Qin N; Zhang M; Liao M; Zeng M; Lu D; Sha O
Front Immunol; 2023; 14():1156038. PubMed ID: 37292206
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 receptor and malignant cancers: Association of
Zhang L; Wei C; Li D; He J; Liu S; Deng H; Cheng J; Du J; Liu X; Chen H; Sun S; Yu H; Fu J
Int J Biol Sci; 2022; 18(6):2362-2371. PubMed ID: 35414771
[TBL] [Abstract][Full Text] [Related]
3. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
Li H; Xie L; Chen L; Zhang L; Han Y; Yan Z; Guo X
Aging (Albany NY); 2020 Nov; 12(22):22370-22389. PubMed ID: 33231569
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.
Zhao MM; Yang WL; Yang FY; Zhang L; Huang WJ; Hou W; Fan CF; Jin RH; Feng YM; Wang YC; Yang JK
Signal Transduct Target Ther; 2021 Mar; 6(1):134. PubMed ID: 33774649
[TBL] [Abstract][Full Text] [Related]
5. Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19.
Katopodis P; Anikin V; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Oncol; 2020 Aug; 57(2):533-539. PubMed ID: 32468052
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients.
Sacconi A; Donzelli S; Pulito C; Ferrero S; Spinella F; Morrone A; Rigoni M; Pimpinelli F; Ensoli F; Sanguineti G; Pellini R; Agrawal N; Izumchenko E; Ciliberto G; Giannì A; Muti P; Strano S; Blandino G
J Exp Clin Cancer Res; 2020 Sep; 39(1):200. PubMed ID: 32967703
[TBL] [Abstract][Full Text] [Related]
7. Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment.
Smieszek SP; Przychodzen BP; Polymeropoulos MH
Int J Antimicrob Agents; 2020 Jun; 55(6):106004. PubMed ID: 32361028
[TBL] [Abstract][Full Text] [Related]
8. A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma.
Li Q; Chen W; Li Q; Mao J; Chen X
Front Immunol; 2022; 13():1019967. PubMed ID: 36225931
[TBL] [Abstract][Full Text] [Related]
9. Expression profile of SARS-CoV-2 cellular entry proteins in normal oral mucosa and oral squamous cell carcinoma.
Sapkota D; Sharma S; Søland TM; Braz-Silva PH; Teh MT
Clin Exp Dent Res; 2022 Feb; 8(1):117-122. PubMed ID: 34726347
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
11. Expressions and significances of CTSL, the target of COVID-19 on GBM.
Dong Q; Li Q; Duan L; Wang H; Yan Y; Yin H; Niu L; Zhang H; Wang B; Yuan G; Pan Y
J Cancer Res Clin Oncol; 2022 Mar; 148(3):599-608. PubMed ID: 34807310
[TBL] [Abstract][Full Text] [Related]
12. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
Front Immunol; 2022; 13():961695. PubMed ID: 36389709
[TBL] [Abstract][Full Text] [Related]
13. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
14. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
Li Z; Shen L; Li Y; Shen L; Li N
Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
[TBL] [Abstract][Full Text] [Related]
15. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
16. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Li B; Zhu J; Meng L
Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
[TBL] [Abstract][Full Text] [Related]
17. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.
Kumar A; Kumar S; Narayan RK; Kumari C; Pareek V; Prasoon P
Viral Immunol; 2021 Jun; 34(5):352-357. PubMed ID: 33481684
[TBL] [Abstract][Full Text] [Related]
18. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
[TBL] [Abstract][Full Text] [Related]
19. Low expression of TMPRSS2-a SARS-CoV-2 internalization protease-associates with basal subtype of head and neck squamous cell carcinoma.
Tiwari J; Tripathi N; Srivastava RS; Kumar S; Singh S; Jain S; Khattri A
Transl Oncol; 2022 Aug; 22():101458. PubMed ID: 35607455
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]